Matthew R Lammi Selected Research

8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- one

2/2015

DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4⁺ T-cell function without causing severe combined immunodeficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew R Lammi Research Topics

Disease

6	Pulmonary Hypertension 01/2022 - 01/2012
5	Chronic Obstructive Pulmonary Disease (COPD) 04/2021 - 10/2015
5	Inflammation (Inflammations) 04/2021 - 07/2015
3	Pulmonary Arterial Hypertension 01/2021 - 03/2016
3	Respiratory Hypersensitivity 01/2016 - 02/2015
3	Eosinophilia 12/2015 - 02/2015
3	Asthma (Bronchial Asthma) 12/2015 - 02/2015
2	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 03/2016
1	Sarcoidosis (Schaumann Disease) 01/2022
1	Familial Primary Pulmonary Hypertension 01/2021
1	Overweight 10/2020
1	Lung Diseases (Lung Disease) 10/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Stroke (Strokes) 01/2020
1	Hypoxia (Hypoxemia) 04/2018
1	Dyspnea (Shortness of Breath) 10/2015
1	Shock 10/2015
1	Critical Illness (Critically Ill) 10/2015
1	Neoplasms (Cancer) 07/2015
1	Glioblastoma (Glioblastoma Multiforme) 02/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2015
1	Disease Progression 11/2014
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 11/2014
1	Obstructive Sleep Apnea 01/2014
1	Heart Failure 01/2012
1	Emphysema 01/2012

Drug/Important Bio-Agent (IBA)

3	AllergensIBA 01/2016 - 02/2015
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 04/2021 - 01/2016
2	Iloprost (Ventavis)FDA Link 04/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 12/2015
2	Oxygen (Dioxygen)IBA 12/2019 - 04/2018
2	olaparibIBA 12/2015 - 07/2015
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2015 - 07/2015
2	OvalbuminIBA 07/2015 - 02/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	insulin receptor-related receptor (IRR)IBA 10/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Phosphodiesterase 5 InhibitorsIBA 03/2016
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2016
1	Endothelin Receptor AntagonistsIBA 03/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2016
1	Pancreatic Elastase (Elastase)IBA 01/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2016
1	ProstaglandinsIBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2015
1	Crystalloid SolutionsIBA 10/2015
1	AlbuminsIBA 10/2015
1	8- dibenzothiophen- 4- yl- 2- morpholin- 4- yl- chromen- 4- oneIBA 02/2015
1	CytokinesIBA 02/2015
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 02/2015
1	Immunoglobulin E (IgE)IBA 02/2015
1	DNA-Activated Protein KinaseIBA 02/2015
1	DNA (Deoxyribonucleic Acid)IBA 02/2015
1	Polynucleotide 5'-Hydroxyl-Kinase (Kinase, Polynucleotide)IBA 02/2015
1	Sildenafil Citrate (Viagra)FDA Link 01/2012

Therapy/Procedure

4	Therapeutics 01/2022 - 10/2015
1	Critical Care (Surgical Intensive Care) 10/2020
1	Catheters 10/2015
1	Transplantation 11/2014
1	Continuous Positive Airway Pressure 01/2014
1	Stents 01/2012